Skip to content

13F-HR filed by Lion Point Capital, LP

Lion Point Capital, LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 31 holding rows worth $242,865,324.

Accession
0001013594-23-000487
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 31 entries on the cover page, a total value of $242,865,324 stated on the cover page (in dollars after the unit check, H1), rows summing to $242,865,324 with VALUE read as dollars as filed, 13F file number 028-17316. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS150,000$61,408,500dollars as filedput
SEMTECH CORP COM816850101Stock2,452,855$59,211,920dollars as filed
CHORD ENERGY CORPORATION674215207COM NEW211,403$28,454,844dollars as filed
ARCONIC ROLLED PRODS CORP03966V107COM712,358$18,685,150dollars as filed
MARINUS PHARMACEUTICALS INC56854Q200COM NEW2,620,096$18,078,662dollars as filed
ARDELYX INC039697107COM2,036,667$9,755,635dollars as filed
PDC ENERGY INC69327R101COM130,398$8,368,944dollars as filed
DURECT CORP266605500COM1,428,306$6,470,226dollars as filed
CIVITAS RESOURCES INC COM NEW17888H103Stock65,000$4,442,100dollars as filed
DIANTHUS THERAPEUTICS INC COM55910K108Stock4,558,466$3,622,613dollars as filed
SERES THERAPEUTICS INC81750R102COM596,803$3,383,873dollars as filed
BURGERFI INTERNATIONAL INC12122L101COM2,745,938$3,240,207dollars as filed
CTI BIOPHARMA CORP12648L601COM601,579$2,526,632dollars as filed
BATTALION OIL CORP07134L107COM380,891$2,502,454dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM97,000$2,329,940dollars as filed
2SEVENTY BIO INC COMMON STOCK901384107Stock170,000$1,734,000dollars as filed
Mersana Therapeutics Inc59045L106Common Stock409,120$1,681,483dollars as filed
Milestone Pharmaceuticals Inc59935V107COM425,207$1,675,316dollars as filed
KINIKSA PHARMACEUTICALS LTDG5269C101COM CL A113,540$1,221,690dollars as filed
ACLARIS THERAPEUTICS INC COM00461U105Stock109,898$889,075dollars as filed
CYMABAY THERAPEUTICS INC23257D103COM99,425$866,986dollars as filed
INSMED INC COM PAR $.01457669307Stock50,335$858,212dollars as filed
ORIGIN MATERIALS INC68622D106COM100,000$427,000dollars as filed
BELLUS HEALTH INC NEW07987C204COM45,000$324,000dollars as filed
SATSUMA PHARMACEUTICALS INC80405P107COM319,742$223,340dollars as filed
LUMOS PHARMA INC55028X109COM51,205$169,489dollars as filed
BURGERFI INTERNATIONAL INC12122L119*W EXP 12/16/2022,083,438$135,423dollars as filedcall
HARPOON THERAPEUTICS INC41358P106COM169,283$125,980dollars as filed
Microsoft Corp594918104COM100$28,830dollars as filed
STRONGHOLD DIGITAL MINING IN86337R103CLASS A COM20,000$12,400dollars as filed
Alphabet Inc. Reg. Shares C02079K107COM100$10,400dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001013594-23-000487this filing2023-05-15acceptance time not in the bulk data set